Interleukin 17A Participates in Renal Inflammation Associated to Experimental and Human Hypertension

• Ngā kaituhi matua: Macarena Orejudo (Author), Raul R. Rodrigues-Diez (Author), Raquel Rodrigues-Diez (Author), Ana Garcia-Redondo (Author), Laura Santos-Sánchez (Author), Javier Rández-Garbayo (Author), Pablo Cannata-Ortiz (Author), Adrian M. Ramos (Author), Alberto Ortiz (Author), Rafael Selgas (Author), Sergio Mezzano (Author), Carolina Lavoz (Author), Marta Ruiz-Ortega (Author)
• Hōputu: Pukapuka
• I whakaputaina: Frontiers Media S.A., 2019-09-01T00:00:00Z.
• Ngā marau: article
• Urunga tuihono: Connect to this object online.

Hypertension is now considered as an inflammatory disease, and the kidney is a key end-organ target. Experimental and clinical studies suggest that interleukin 17A (IL-17A) is a promising therapeutic target in immune and chronic inflammatory diseases, including hypertension and kidney disease. Eleva...